Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis

Rheumatology (United Kingdom)

Volumn 52, Issue 3, 2013, Pages 448-451

  Konsta, Maria ^a   Bamias, Giorgos ^a   Tektonidou, Maria G ^a   Christopoulos, Panayiotis ^a   Iliopoulos, Alexios ^b   Sfikakis, Petros P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Veterans Administration Hospital   (Greece)

Author keywords

Ankylosing spondylitis; Anti TNF therapy; TL1A; TNF

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; CYTOKINE 1A; ETANERCEPT; INFLIXIMAB; SOLUBLE TNF LIKE CYTOKINE 1A; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ANKYLOSING SPONDYLITIS; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SEX RATIO; SPINE MOBILITY;

ADOLESCENT; ADULT; AGED; ANTIRHEUMATIC AGENTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; YOUNG ADULT;

EID: 84874103388     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes316     Document Type: Article

References (16)

1. Braun J, Bollow M, Neure L et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995;38: 499-05.
2. François RJ, Neure L, Sieper J, Braun J. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor a in two patients with early disease and transforming growth factor {beta} in three more advanced cases. Ann Rheum Dis 2006;65: 713-0.
3. van der Heijde D, Sieper J, Maksymowych WP et al. Assessment of SpondyloArthritis International Society. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 2011;70:905.
4. Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 2009;9:271-5.
5. Migone TS, Zhang J, Luo X et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002;16:479-2.
6. Bull MJ, Williams AS, Mecklenburgh Z et al. The death receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. J Exp Med 2008; 205:2457-4.
7. Bamias G, Siakavellas SI, Stamatelopoulos KS, Chryssochoou E, Papamichael C, Sfikakis PP. Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor (DcR3) in rheumatoid arthritis. Clin Immunol 2008; 129:249-5.
8. Zhang J, Wang X, Fahmi H et al. Role of TL1A in the pathogenesis of rheumatoid arthritis. J Immunol 2009;183: 5350-5357.
9. Bamias G, Evangelou K, Vergou T et al. Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions. Exp Dermatol 2011;20:725-1.
10. Shih DQ, Michelsen KS, Barrett RJ et al. Insights into TL1A and IBD pathogenesis. Adv Exp Med Biol 2011;691: 279-8.
11. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007; 369:1379-0.
12. Machado P, Landewé R, Lie E et al. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 2011;70:47-3.
13. Bayry J. Immunology: TL1A in the inflammatory network in autoimmune diseases. Nat Rev Rheumatol 2010;6:67-8.
14. Shih DQ, Barrett R, Zhang X et al. Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis. PLoS One 2011;6:e16090.
15. De Keyser F, Baeten D, Van den Bosch F et al. Gut inflammation and spondyloarthropathies. Curr Rheumatol Rep 2002;4:525-2.
16. Hsu H, Viney JL. The tale of TL1A in inflammation. Mucosal Immunol 2011;4:368-0.